Clever, Personable, and Unconventional: A Look at Assertio Holdings Inc.’s Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Lake Forest, Ill, Jan. 06, 2023 (GLOBE NEWSWIRE) Company Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that as of January 3, 2023, the Compensation Committee of the Company’s Board of Directors granted…

Read More

O’Reilly Automotive Inc. Announces Executive Leadership Promotions: A Heartfelt and Insightful Update on the Company’s Growth

O’Reilly Automotive, Inc. Announces Executive Leadership Promotions Brad Beckham and Brent Kirby to be Promoted to Co-Presidents Greg Johnson to remain Chief Executive Officer SPRINGFIELD, Mo., Jan. 06, 2023 (GLOBE NEWSWIRE) — O’Reilly Automotive, Inc. (the “Company” or “O’Reilly”) (Nasdaq: ORLY), a leading retailer in the automotive aftermarket industry, announced executive leadership promotions. Effective January…

Read More

Clever, Personable, and Unconventional: UPD Holding Corp. Returns to Beverage Business with New Director and Debt Cancellation

Celebrating UPD Holding Corp.’s Re-Entry Into the Beverage Business New Beginnings with Specialty Waters and Functional Beverages Exciting news has emerged from UPD Holding Corp. (OTC:UPDC), as the company announces its re-entry into the beverage business with a focus on specialty waters and functional beverages. This bold move showcases UPDC’s commitment to innovation and growth…

Read More

Important Class Action Reminders for CTXS, GAIA, and DAKT Investors: Don’t Miss Out on Your Opportunity to Participate!

Class Action Lawsuit Reminder New York, Jan. 06, 2023 (GLOBE NEWSWIRE) Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Law…

Read More

Maximize Your Investment Potential: Submit Your Losses to Johnson Fistel for Fate Therapeutics Shareholder Investigation

Fate Therapeutics Shareholder Investigation: Submit Your Losses to Johnson Fistel FATE Class Action Investigation has Been Commenced on Behalf of Shareholders SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP is investigating whether Fate Therapeutics, Inc. (NASDAQ: FATE) (“Fate” or the “Company), any of its executive officers, or others…

Read More

Deception Technology Solutions on the Rise: Spike in APTs and Zero-Day Attacks to Drive Demand – According to Fact.MR Report

Global Deception Technology Market Expanding Significantly Spike in APTs and Zero-Day Attacks Driving Demand Rising Need for Effective Solutions for Early Identification of Attackers Rockville, Jan. 06, 2023 (GLOBE NEWSWIRE) — Fact.MR, a market research and competitive intelligence provider, reveals that the global deception technology market is experiencing significant growth. This growth is being driven…

Read More

OrthoPediatrics Corp Expands into Germany with New Direct Sales Organization: A Game-Changing Move in the World of Orthopedic Medicine

OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organization in Germany. Expanding Commitment OrthoPediatrics GmbH commenced operations on January 1,…

Read More

Unlocking the Potential: Hypophosphatasia Treatment Market Projected to Reach $26.27 Million by 2033, with a 5% CAGR – Insights from Future Market Inc.

Hypophosphatasia Treatment Market: A Growing Industry Asia Pacific to Lead the Way The Asia Pacific hypophosphatasia treatment market is projected to experience the highest CAGR of 4.8% during the forecast period of 2023 to 2033. Within this region, the Odontohypophosphatasia segment is expected to see a CAGR of 4.9% over the analysis period. This rapid…

Read More